drugset / Trial / NCT04271917
Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.
Timeline
- Start
- 2020-02-24
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 17 mg/ml | Other |
| Subject | Cannabidiol | Other / unclassified | 37 mg/ml | Other |
| Comparator | Acetaminophen | Small molecule | 500 mg | Oral |
| Comparator | Ibuprofen | Small molecule | 200 mg | Oral |
Indications
No indication recorded.